Efficient viral transduction in mouse inner ear hair cells with utricle injection and AAV9-PHP.B

• Published in: Hearing research 2020-09, Vol.394, p.107882-107882, Article 107882
• Main Authors: Lee, John, Nist-Lund, Carl, Solanes, Paola, Goldberg, Hannah, Wu, Jason, Pan, Bifeng, Schneider, Bernard L., Holt, Jeffrey R.
• Format: Article
• Language: English
• ISSN: 0378-5955; 1878-5891
• DOI: 10.1016/j.heares.2020.107882

Viral delivery of exogenous coding sequences into the inner ear has the potential for therapeutic benefit for patients suffering genetic or acquired hearing loss. To devise improved strategies for viral delivery, we investigated two injection techniques, round window membrane injection or a novel utricle injection method, for their ability to safely and efficiently transduce sensory hair cells and neurons of the mouse inner ear. In addition, we evaluated three synthetic AAV vectors (Anc80L65, AAV9-PHP.B, AAV2.7m8) encoding enhanced green fluorescent protein (eGFP) and three promoters (Cmv, Synapsin, Gfap) for their ability to transduce and drive expression in desired cell types. We found the utricle injection method with AAV9-PHP.B and a Cmv promoter was the most efficient combination for driving robust eGFP expression in both inner and outer hair cells. We found eGFP expression levels rose over 3–5 days post-injection, a viral dose of 1.5 × 109 gc yielded half maximal eGFP expression and that the utricle injection method yielded transduced hair cells even when delivered as late as postnatal day 16. Sensory transduction and auditory thresholds were unaltered in injected mice relative to uninjected wild-type controls. Vestibular end organs were also transduced without affecting balance behavior. The Synapsin promoter and the Gfap promoter drove strong eGFP expression in inner ear neurons and supporting cells, respectively. We conclude the AAV9-PHP.B vector and the utricle injection method are well-suited for delivery of exogenous gene constructs into inner ears of mouse models of auditory and vestibular dysfunction. •A novel utricle injection method delivers viral vectors safely to the inner ear.•AAV9-PHP.B drives efficient gene expression in inner ear hair cells and neurons.•Dose-response and time course of viral gene expression characterized.•Vestibular hair cells efficiently transduced with AAV9-PHP.B.•Cell-type selective promoters drive expression in neurons and supporting cells.